




















































neurodevelopment,	 offering	 a	 time	 window	 for	 therapeutic	 intervention.	 Epidemiological	 data	 has	
revealed	 that	 infections	 during	 pregnancy	 increase	 the	 risk	 of	 psychiatric	 illnesses,	 such	 as	 ASD	 and	
schizophrenia,	 in	 children.	 Indeed,	 similarities	 in	 psycho-	 and	 neuropathologies	 between	 the	 two	
disorders	suggest	that	there	may	be	a	common	etiology.	Animal	models	of	maternal	immune	activation	












neonatal	piglet	offspring.	Postnatal	microglia	 isolated	 from	these	animals	did	not	differ	 from	controls,	






brain	 region	 that	 displays	 ongoing	 concentrated	 neurogenesis,	 making	 it	 exceptionally	 vulnerable	 to	
maternal	insults.	We	found	that	maternal	infection	reduced	neuron	number	and	caused	astrocyte-specific	






the	 central	nervous	 system.	Notably,	 there	was	an	absence	of	pronounced	neuroinflammation	at	 this	
time,	 including	 an	 apparent	 reduction	 in	 microglial	 cell	 activation,	 which	 indicated	 that	 classical	
neuroinflammatory	pathways,	if	activated	by	MIA,	are	mostly	resolved	by	parturition.	The	third	section	of	
this	 dissertation,	 therefore,	 focused	 on	 investigating	 neuroinflammation,	 and	 specifically	 microglia	
activation,	 at	 earlier	 time	 points:	 peak	 maternal	 viral	 infection	 (7	 days-post-inoculation	 [dpi])	 and	
immediately	following	the	resolution	of	maternal	symptoms	(21	dpi).	
	 At	21	dpi,	we	observed	a	reduction	in	fetal	brain	weights,	but	not	body	weights,	due	to	maternal	
viral	 infection,	 replicating	 our	 previous	 findings.	 Assessment	 of	 gene	 expression	 revealed	 increased	
inflammation	at	the	maternal-fetal	interface	(endometrium	and	placenta)	at	both	7	and	21	dpi.	Evaluation	















































































































































disorders	 to	 a	 common	 etiology	 relevant	 for	 induction	 of	 either	 pathological	 phenotype;	 specifically,	
increased	fetal	neuroinflammation	during	maternal	infection	[3].		
Interest	in	the	link	between	prenatal	maternal	infection	and	the	prevalence	of	neuropsychiatric	




for	 the	 diagnosis	 of	 ASD:	 (1)	 deficits	 in	 social	 communication	 and	 interactions,	 and	 (2)	 patterns	 of	
restricted,	 repetitive	 behaviors,	 interests,	 or	 activities.	 Over	 the	 past	 decade,	 the	 incidence	 of	 ASD	
diagnoses	in	the	United	States	has	steadily	risen,	though	it	is	difficult	to	say	whether	this	rise	is	due	to	
more	comprehensive	diagnostic	criteria	or	increased	awareness	[4].	The	most	recent	report	from	the	CDC	





Schizophrenia	 is	characterized	by	two	or	more	of	 the	 following	 five	symptoms	per	the	DSM-5:	
delusions,	hallucinations,	disorganized	speech,	grossly	disorganized	or	catatonic	behavior,	and	negative	
symptoms	 such	 as	 diminished	 emotional	 expression.	 The	 illness	 is	 also	 characterized	 by	
social/occupational	dysfunction	[9].	Though	less	than	1%	of	the	population	suffers	from	schizophrenia,	
the	cost	to	society	is	disproportionately	large	considering	the	functional	impairments	associated	with	the	







It	 appears	 that	 both	ASD	 and	 schizophrenia	 share	 psycho-	 and	neuropathologies	 that	may	be	
linked	 to	prenatal	maternal	 infection	 [3],	 so	defining	 these	pathways	 could	be	 the	 key	 component	 to	
delineating	 a	 shared	 etiology,	 and	 thus	 developing	 efficacious	 preventative	 therapies	 that	 could	 be	
implemented	 prenatally.	 It	 is	 also	 important	 to	 note	 that	 epidemiological	 studies	 assessing	maternal	
infection	and	the	incidence	of	psychiatric	disorders	indicate	that	the	presence	of	a	pathogenic	infection,	
regardless	 of	 the	 transmission	 and	 type,	 presents	 a	 threat	 to	 the	 offspring.	 For	 example,	 both	
transmissible	 (rubella	 virus,	 cytomegalovirus,	 herpes	 simplex	 virus,	 toxoplasma	 gondii)	 and	 non-
transmissible	 (influenza	 virus)	 pathogens	 confer	 risk	 [1,	 2],	 bolstering	 the	 idea	 that	 a	 robust	 immune	
response,	and	not	the	type	of	initiating	pathogen,	is	the	driving	factor.		
1.2	Innovation	
Though	 there	 are	many	 established	preclinical	 rodent	models,	 and	 a	 few	non-human	primate	
models,	for	investigating	maternal	infection,	we	are	the	only	lab	to	establish	a	maternal	immune	activation	
(MIA)	model	in	swine	(to	our	knowledge).	Swine	are	particularly	suited	for	investigating	the	impacts	of	






that	we	are	 aware	of.	 In	 addition,	 the	pig	 is	 increasingly	 recognized	as	 an	 ideal	model	 for	biomedical	
studies,	as	the	porcine	immunome	resembles	humans	in	80%	of	the	parameters	analyzed	(versus	less	than	
10%	 for	mice)[17,	18].	Next	 to	 the	primate	and	murine	 immune	 system,	 the	 swine	 immune	 system	 is	
extremely	well	characterized	[19,	20]	and,	thanks	to	complete	sequencing	of	the	swine	genome,	a	wide	





18.5	 and	 21	 days	 in	mice	 and	 rats,	 respectively)	 enables	 targeting	 of	 specific	 gestational	 time	 points	











palpable	benefit	 compared	 to	 lissencephalic	murine	models.	Though	 there	are	a	 few	established	non-
human	primate	MIA	models,	several	factors	such	as	cost,	housing	logistics,	biomedical	research	approval,	
and	the	long	lifespan	of	non-human	primates	causes	difficulties	in	obtaining	data	on	the	impacts	of	MIA	






points	 relevant	 to	 the	 peak	 and	 resolution	 of	maternal	 infection,	 which	 represent	 not	 only	 essential	
periods	 of	 neurodevelopment,	 but	 also	 critical	 time	 points	 in	 delineating	 the	 immediate	 effects	 of	
maternal	infection	on	neuroimmune	parameters	of	gestating	and	newborn	offspring;	these	time	points	
have	largely	been	ignored	in	the	MIA	literature	until	recently.	Lastly,	we	aimed	to	specifically	investigate	


















fetal	 hippocampus	 immediately	 prior	 to	 parturition,	 when	 maternal	 symptoms	 have	 resolved.	 We	






















or	the	bacterial	endotoxin	 lipopolysaccharide	(LPS),	demonstrate	that	fetal	neuroinflammation	 is	 likely	
derived	from	a	heightened	exposure	to	maternal	cytokines	[24-29],	creating	an	imbalance	of	inflammatory	
signaling	in	the	fetal	brain	[30].	Induction	of	MIA	in	pregnant	animals	results	in	offspring	that	display	core	
behavioral	 symptoms	 of	 both	 ASD	 (such	 as	 reduced	 social	 behavior,	 disruptions	 in	 vocalizations,	 and	
stereotypic	 behaviors	 [31,	 32])	 and	 schizophrenia	 (impaired	 cognition,	 delayed	 pre-pulse	 inhibition,	
altered	locomotor	activity,	and	anhedonia	[24,	33]).	Indeed,	preliminary	clinical	studies	support	the	idea	






blocking	 IL-6	 through	 genetic	 methods	 (IL-6	 knock	 outs)	 or	 neutralizing	 antibodies	 prevented	 the	
behavioral	abnormalities	induced	by	maternal	poly	I:C	treatment	[26].	Follow-up	work	by	the	same	group	
indicated	that	maternally	derived	IL-6	protein	and	IL-6	mRNA	were	upregulated	in	the	placenta,	leading	
to	 local	 immune	 cell	 infiltration	 and	 a	 disruption	 in	 growth	 hormone	 levels	 during	 gestation,	 and	
culminating	 in	altered	behaviors	 in	adult	offspring	 [36].	More	 recently,	Wu	et	al.	 (2016)	 revealed	 that	
placental	 IL-6	 signaling	 is	 indeed	 required	 for	maternal-fetal	 transmission	of	 inflammatory	signals	 that	
induce	neurodevelopmental	and	behavioral	pathologies	seen	 in	these	MIA	models,	and	that	restricted	
deletion	of	 the	 IL-6	 receptor	on	placental	 trophoblasts	prevented	 these	pathologies	 [27].	Additionally,	
intracellular	downstream	 IL-6	 signaling,	 through	phosphorylation	of	 signal	 transducer	 and	activator	of	
transcription	 (STAT3),	 is	 increased	 in	 fetal	 brains	 exposed	 to	maternal	 LPS	 treatment,	 but	 blunted	 by	
maternal	 administration	 of	 IL-6	 blocking	 antibody	 [28].	 In	 vitro	 work	 also	 suggests	 that	 inflammatory	









Interestingly,	 recent	evidence	shows	that	 IL-17a	 is	also	sufficient	 to	produce	abnormal	cortical	
development	and	ASD-like	phenotypes	[25,	38,	39],	and	that	administration	of	IL-17a-blocking	antibody	















on	 fetal	 brain	 development	 during	MIA,	 specifically	 under	 varying	 gut	microbiome	 compositions	 and	
pathogen	 exposures.	 Tissues	 outside	 the	 maternal	 gut	 and	 fetal	 brain	 should	 also	 be	 taken	 into	
consideration,	specifically	fetal	tissues	like	the	placenta	(which	contains	IL-6	receptors	utilized	in	direct	IL-
6	 signaling)	 and	amniotic	 fluid.	 Though	 this	maternal-fetal	 interface	has	been	 largely	neglected	 in	 the	
literature	thus	far,	this	boundary	likely	plays	a	large	role	in	the	etiology	of	brain	pathologies	induced	by	
MIA	[27,	36,	43-47]	and	should	not	be	ignored.	









received	the	same	poly	 I:C	 injection	at	E15.5	or	E18.5	[38].	Gestational	timing	(middle	vs.	 late)	of	MIA	
induction	 also	 differentially	modulates	 offspring	 neurogenesis,	 cell	 apoptosis,	 and	 neuroinflammation	
[48].	As	 stated	above,	Kim	et	 al.	 (2017)	have	established	 the	 importance	of	particular	microbiota	and	
dendritic	cell	subsets	in	the	guts	of	dams	prior	to	immune	stimulation,	which	directs	both	the	type	and	
the	amount	of	maternal	cytokines	that	are	released	during	MIA	[39].	Others	have	shown	that	even	within	
identical	murine	strains	there	are	high	and	 low	maternal	 immune	responders	 (primarily	predicated	on	
production	of	TNFα),	which	determines	the	presence	or	absence	of	certain	behavioral	abnormalities	in	
offspring	[33].		
Lastly,	 the	 type	 and	 dose	 of	 the	 immune	 stimulator	 understandably	 dictates	 the	 nature	 and	
severity	 of	 the	maternal	 response	 and,	 consequently,	 the	 fetal	 response.	 There	 are	multiple	ways	 of	
inducing	maternal	immune	activation,	all	of	which	exist	in	the	literature	and	have	varying	pros	and	cons	
in	 relation	 to	 the	practicalities	of	working	with	 the	model	 (i.e.	biosafety)	 and	 its	 translatability.	 These	
include	 live	 viral	 or	 bacterial	 challenges	 (such	 as	 influenza	 virus	 or	 bacteria	 involved	 in	 periodontal	
disease),	 viral	 or	 bacterial	mimetics	 (poly	 I:C	 and	 LPS,	which	 have	 primarily	 been	 discussed	 thus-far),	
stimulators	 of	 local	 inflammation	 (such	 as	 turpentine),	 teratogens	 (like	 valproic	 acid),	 or	 immune	
molecules	 themselves,	 which	 include	 maternal	 antibodies	 reactive	 to	 fetal	 brain	 proteins	
(immunoglobulin	G;	IgG)	and	recombinant	cytokines	(IL-6	and	IL-17a,	for	example)	[50-53].	Though	not	




literature.	One	of	 these	mechanisms,	as	was	previously	described,	 is	 the	direct	mediation	of	offspring	
outcomes	by	maternal	cytokines.		
2.2	Microglia	in	the	Context	of	Maternal	Immune	Activation	
Though	 evidence	 linking	 the	 etiology	 of	 MIA-induced	 abnormalities	 with	 maternal	 cytokines	
continues	 to	 accumulate,	 less	 is	 known	 about	 the	 involvement	 of	microglial	 cells;	 nonetheless,	 these	



















during	 the	 last	 decade,	 as	 evidence	 demonstrating	 their	 integral	 involvement	 in	 neurogenesis,	
synaptogenesis,	myelination,	and	angiogenesis	greatly	expanded	(see	[61,	63,	68]	and	[69]	for	review).	In	
addition,	 though	 categorization	 of	 microglia	 activation	 states	 originally	 adopted	 the	 canonical	





yet	only	a	small	percentage	of	these	newborn	cells	are	ultimately	 incorporated	 into	the	 local	circuitry,	




that	 resting	 microglia	 migrate	 to	 experimentally	 stimulated	 hyperactive	 axons;	 ramified	 microglial	
processes	wrap	 affected	 axons,	 swiftly	 returning	membrane	 potentials	 to	 resting	 states,	 and	 clearing	
axonal	debris.	Blocking	microglial	migration	caused	neuronal	cell	death	[76],	indicating	that	the	actions	of	
ramified	 ‘resting’	 microglia	 carry	 out	 integral	 neuroprotective	 and	 phagocytic	 functions	 despite	 their	












these	cells	are	essential	 for	establishing	brain	circuitry,	 such	that	 removing	microglia	caused	excessive	
growth	and	distribution	of	neurons	[79].	Other	evidence	supports	the	idea	that	microglia	communicate	
bi-directionally	 with	 neurons,	 allowing	 for	microglia-regulated	 neuronal	 elimination	 and	 survival	 [61].	
Cunningham	et	al.	(2013)	have	shown	that	induction	of	MIA	in	rats	causes	increased	phagocytic	activity	
of	microglia,	leading	to	a	reduction	of	neural	progenitor	cells	in	fetal	brains	[60].	Thus,	there	is	sufficient	
evidence	 to	 suggest	 that	 a	 perturbation	 of	 microglia	 cells	 during	 development	 can	 have	 widespread	
consequences	on	neuronal	development	and	circuitry.	Indeed,	MIA	caused	alterations	in	genome-wide	





experiments	 demonstrating	 that	 synapses	 are	 eliminated	 through	 the	 classical	 complement	 cascade,	
leading	to	deposition	of	C3	opsonizing	protein,	which	tags	the	synapse	for	phagocytosis	[81].	A	later	study	
by	Allison	Bialas	and	Beth	Stevens	(2013)	demonstrated	that	astrocyte-derived	TGF-𝛽	 is	necessary	and	
sufficient	 for	 the	 upregulation	 of	 C1q	 in	 neighboring	 neurons;	 importantly,	 the	 authors	 showed	 that	
upregulation	of	synaptic	C1q	was	required	for	complement-driven	phagocytosis	by	microglia	[82].	A	few	
years	earlier,	Paolicelli	et	al.	(2011)	had	shown	that	synaptic	remodeling	may	be	in	some	part	dependent	
on	 fractalkine	 signaling,	 as	 fractalkine	 receptor	 knock-out	 mice	 had	 reduced	 synaptic	 pruning	 and	
displayed	a	phenotype	of	“exuberant	immature	synapses”	[83].	Microglia,	the	sole	CNS	cells	expressing	
CR3	(CD11b/CD18;	the	receptor	for	opsonizing	protein	C3)	and	fractalkine	receptor	CX3CR1,	are	therefore	
integrally	 involved	 in	 regulating	 both	 synaptic	 pruning	 and	 remodeling	 during	 development	 [61,	 69].	
















for	 dysregulation	 in	 the	 function	 and	 plasticity	 of	 the	 tetrapartite	 synapse	 in	 neurodevelopmental	
disorders,	specifically	schizophrenia,	has	recently	emerged,	and	new	data	indicate	that	these	tetrapartite	
synapse	abnormalities	occur	in	discrete	cortical	and	amygdalar	regions	[96].	
Disrupted	 neurodevelopmental	 circuitries	 and	 synaptic	 pruning	 like	 that	 presented	 above	 can	
manifest	 in	 various	 ways	 in	 the	 context	 of	 neuropathology.	 In	 particular,	 ASD	 brains	 are	 often	
characterized	by	altered	cortical	thickness/layering	[97]	and	cell	patterning	[98],	altered	neurogenesis	[97,	




With	 new	 research	 emerging	 on	 the	 action	 of	 microglial	 cells	 during	 development,	 sexual	
dimorphisms	in	microglia	across	developing	male	and	female	brains	have	also	become	apparent	[64,	109].	




model	 showing	 sex-dependent	 abnormalities	 in	microglia	 in	 the	 adult	 cortex	 and	 hippocampus	 [110].	
Interestingly,	 environmental	 factors	 such	 as	 the	 gut	 microbiome	 have	 recently	 been	 shown	 to	 have	




118].	 The	 popular	 theory	 describing	 the	 involvement	 of	microglia	 in	 psychiatric	 illness	 surrounds	 the	
concept	of	“microglia	priming”	or	“psychological	immune	memory”,	wherein	a	psychological	or	immune	
stressor	early	 in	 life	 results	 in	an	over-activation	of	microglia,	 leading	to	prolonged	hyper-activation	 in	
adolescent	 and	 adult	 brains,	 even	 after	 the	 stressor	 is	 removed	 [16,	 119,	 120].	However,	 conclusions	














long-lived;	early	 reports	suggested	that	population	turnover	was	slow,	 though	even	at	 the	time	 it	was	
acknowledged	 that	 methodological	 limitations	 likely	 resulted	 in	 an	 underestimation	 of	 microglia	
proliferation	[127].	Askew	et	al.	(2017)	revisited	this	concept	in	the	last	year,	discovering	that	microglial	
turnover	rates	in	the	adult	brain	are	actually	much	higher	than	expected,	and	result	in	a	complete	renewal	
and	 comprehensive	 restructuring	 of	 the	 microglial	 landscape	 approximately	 every	 96	 days	 [128].	




Consequently,	microglia	 that	 are	 influenced	by	 gestational	 insults	 are	 likely	 to	 show	 the	most	
robust	responses	during	the	prenatal	period.	However,	few	researchers	have	investigated	the	activity	and	
phenotypes	of	microglia	immediately	following	exposure	to	MIA,	and	the	present	literature	on	this	topic	
is	 conflicting.	 Cunningham	 et	 al.	 (2013)	 found	 that	 two	 i.p.	 injections	 of	 bacterial	 endotoxin	 LPS	 into	
pregnant	rats	at	E15	and	E16	induced	heightened	expression	of	inducible	nitric	oxide	synthase	(iNOS)	and	
the	 proinflammatory	 cytokine	 IL-1β	 by	 fetal	 microglia,	 indicative	 of	 a	 phenotypic	 shift	 to	 cytotoxic	
activation.	Notably,	this	shift	towards	a	more	inflammatory	state	coincided	with	a	significant	reduction	in	
neural	precursor	cells	in	the	proliferative	zones	of	the	cerebral	cortex,	both	four	and	ten	days	after	LPS	
















Interestingly,	 Smolders	 et	 al.	 (2015)	 also	 conducted	ex	 vivo	 studies	on	embryonic	brain	 slices,	
treating	with	 IL-6,	 poly	 I:C,	 and	 LPS;	 only	 LPS	 could	 directly	 activate	microglia	ex	 vivo,	 indicating	 that	






























in	 its	 formation,	 remain	 to	 be	 fully	 elucidated,	 yet	 recent	 evidence	 suggests	 that	microglia	 activity	 is	
directly	 related	 to	 social	 behavior.	Mice	deficient	 in	CX3CR1	 (causing	depletion	of	microglia)	 exhibited	
decreased	functional	connectivity	between	the	medial	prefrontal	cortex	and	the	hippocampus,	which	was	




demonstrated,	 fetal	 mice	 exposed	 to	 an	 LPS	 model	 of	 MIA	 display	 a	 pro-inflammatory	 microglia	
phenotype	 that	 significantly	and	 lastingly	 reduces	 the	number	of	 cortical	neurons	 [60],	 indicating	 that	
microglia	 activation,	 however	 transient,	 may	 have	 permanent	 effects	 on	 brain	 development	 and	
subsequent	behavior,	perhaps	through	altering	connectivity	and	synchronization	pathways.		
Though	microglia	were	not	examined	by	Shin	Yim	et	al.	(2017),	this	group	demonstrated	that	MIA	





deficits	 in	MIA	animals	 [38].	 Intriguingly,	other	behavioral	abnormalities	 (specifically	marble	burying,	a	
proxy	for	restricted,	repetitive	behaviors)	were	not	impacted	by	stimulating	or	inhibiting	input	to	the	TeA.	
These	data	indicate	that	an	imbalance	in	excitation	and	inhibition	in	this	discrete	neural	circuit	is	likely	













dysregulation	 is	 common	 in	 neurological	 disorders	 like	 ASD	 and	 schizophrenia	 (summarized	 above),	










	 Microglia	 colonize	 the	 embryonic	 brain	 during	 early	 neurodevelopment,	 establishing	 an	
environment	 conducive	 to	 proper	 neural	 and	 glial	 network	 organization,	 of	 which	 they	 are	 integral	
mediators.	 Inhibition,	 depletion,	 or	 ablation	 of	 these	 cells	 during	 development	 is	 detrimental	 to	
neurogenesis	and	to	the	formation	of	proper	neural	networks,	as	well	as	to	synaptogenesis	and	pruning.	
Animal	models	of	maternal	immune	activation	suggest	that	embryonic	microglia	are	activated	in	response	
to	 maternal	 inflammation,	 which	 alters	 their	 ability	 to	 properly	 perform	 integral	 neurotrophic	 and	
phagocytic	 tasks.	 This	 is	 a	 likely	 mechanism	 through	 which	 MIA	 leads	 to	 behavioral	 abnormalities	
reminiscent	of	psychiatric	disorders	like	ASD	and	schizophrenia.	Aberrant	regulation	of	immune	responses	
within	the	brain,	including	depletion	of	microglia,	has	been	shown	to	alter	social	behaviors	in	preclinical	
models,	 suggesting	 that	 altered	 fetal	 immune	 responses	 during	 MIA	 is	 primary	 to	 the	 etiology	 of	
idiosyncrasies	in	social	behavior.	Thus,	defining	the	actions	of	microglia	in	the	context	of	MIA	is	vital	to	











Maternal	 infection	 during	 pregnancy	 increases	 risk	 for	 neurodevelopmental	 disorders	 and	
reduced	stress	resilience	in	offspring,	but	the	mechanisms	are	not	fully	understood.	We	hypothesized	that	





weaned	 at	 postnatal	 day	 (PD)	 1	 and	 assigned	 to	 two	 groups.	 Group	 1	 was	 challenged	 with	
lipopolysaccharide	(LPS,	5	µg/kg	body	weight	i.p.)	or	saline	on	PD	14	and	tissues	were	collected.	Group	2	


























Maternal	 infection	 during	 pregnancy	 is	 associated	 with	 increased	 risk	 for	 development	 of		
neuropsychiatric	 disorders,	 such	 as	 autism	and	 schizophrenia,	 in	 offspring	 [1,	 144].	 	 Studies	 in	 animal	













resident	 immune	 cells	 of	 the	 brain,	 have	 been	 implicated	 in	 the	 neuroimmune	 pathogenesis	 of	
neurodevelopmental	 disorders	 (Onore,	 Careaga,	 and	 Ashwood,	 2012).	 Microglia	 are	 derived	 from	
progenitor	 cells	 in	 the	 yolk	 sac	 [58]	 and	 colonize	 proliferative	 zones	 of	 the	 neocortex	 during	 the	 first	
trimester	 of	 prenatal	 development	 [60].	 Fetal	microglia	 display	 both	 ramified	 (resting)	 and	 amoeboid	
(activated	or	proliferating)	morphologies	and	participate	in	brain	development	through	phagocytosis	of	
neural	precursor	cells,	neurons,	and	neuronal	synapses	[60,	65,	66].	Fetal	microglia	express	many	of	the	
typical	 macrophage	 markers	 and	 express	 inflammatory	 genes	 associated	 with	 both	 classical	 pro-
inflammatory	and	alternative	anti-inflammatory	phenotypes	[60].	Fetal	mice	exposed	to	the	LPS	model	of	




long	 term,	 resulting	 in	 prolonged	 neuroinflammation	 [16,	 60],	 consistent	 evidence	 in	 support	 of	 this	
hypothesis	is	lacking.	
















growth	 spurt,	 similar	 to	 human	 neurodevelopment	 [13-15].	 The	 domestic	 pig	 is	 a	 precocious,	
gyrencephalic	species	whose	brain	anatomy,	neurochemistry,	and	growth	and	development	trajectories	
correspond	closely	 to	humans	 in	prenatal	and	early	postnatal	 life	 [12,	23].	Thus,	we	sought	 to	extend	
current	 findings	 on	 MIA	 in	 a	 highly	 translatable	 pig	 model.	 As	 data	 demonstrating	 prolonged	 over-
activation	of	microglia	in	offspring	due	to	MIA	are	lacking,	and	recent	evidence	indicates	that	prolonged	
microglia	 anomalies	 may	 not	 occur	 in	 some	 MIA	 models	 [121,	 122],	 we	 aimed	 to	 assess	 microglia	
activation	status	in	prenatally	challenged	neonatal	piglets.	We	hypothesized	that	maternal	infection	with	
PRRSV	would	 lead	 to	 aberrant	microglia	 activity	 in	 offspring,	 resulting	 in	 altered	 cognitive	 and	 social	
behaviors	in	early	life.	We	further	postulated	that	maternal	infection	would	alter	fetal	HPA	development	
and	 lead	to	GC	resistance	 in	microglia.	Here,	we	show	that	piglets	born	from	infected	mothers	display	









of	 a	 standard	 corn-soybean	 meal-based	 gestation	 diet	 daily,	 with	 ad	 libitum	 access	 to	 water.	 Rectal	



























confirm	presence/absence	of	PRRSV;	 and	 intramuscular	 injections	of	 iron	dextran	 (100	mg/pig,	Butler	
Schein	Animal	Health,	Dublin,	OH)	and	penicillin	(60	kU/pig,	Butler	Schein	Animal	Health,	Dublin,	OH)	were	






























serum	was	collected	and	stored	at	 -80°	C	until	analysis.	 .	 Immediately	 following,	Group	1	piglets	were	


























arms	 (east	 and	 west),	 with	 four	 different	 extra-maze	 visual	 cues.	 Start	 arms	 were	 pseudorandomly	
alternated	so	that	piglets	had	to	use	an	allocentric	 (hippocampus-dependent)	mechanism	to	solve	the	






of	 chocolate	milk	was	provided	at	each	 trial.	Once	 the	acquisition	criterion	of	80%	 (8	out	of	10	 trials)	
correct	was	reached,	the	location	of	the	reward	bowl	was	switched	(the	reversal	phase).	During	reversal	
(5	d),	piglets	performed	the	task	as	before	until	80%	criteria	was	reached	once	more.	Throughout	testing,	




























Six	 age-matched	 piglets	 were	 used	 as	 novel	 piglets	 (see	 above)	 and	 underwent	 extensive	




one	 PRRSV	 piglet	 had	 to	 be	 excluded	 from	 analyses	 due	 to	 improper	 automated	 tracking.	
Exploratory/social	 behaviors—defined	 as	 piglet’s	 nose	 in	 contact	 with	 the	 crate—were	 scored	 by	 an	




of	 CD11b.	 Cell	 isolation	 was	 performed	 using	 Miltenyi	 Biotec	 GentleMACS	 C-tubes,	 Neural	 Tissue	
Dissociation	Kits	 (P),	GentleMACS	Octo	Dissociator	with	Heaters,	CD11b	(microglia)	MicroBeads,	MACS	

















with	 100	 U/mL	 penicillin/streptomycin,	 10%	 FBS,	 and	 1	 µL/mL	 porcine	 rpGM-CSF	 (R&D	 Systems,	
Minneapolis,	MN)].	Cells	from	the	right	hemisphere	of	the	hippocampus	were	resuspended	in	standard	
medium	plus	dexamethasone	(DEX,	3.18	µM,	Sigma-Aldrich,	St.	Louis,	MO).	DEX,	a	synthetic	GC,	binds	
glucocorticoid	 receptors	 [173]	 and	modulates	 inflammatory	 gene	 expression	 by	 inhibiting	NF-κB.	 The	
dose	 of	 DEX	 was	 chosen	 based	 on	 a	 prior	 study	 showing	 it	 achieves	 50%	 inhibition	 of	 in	 vitro	 LPS-
stimulated	 cytokine	 production	 in	 the	 whole	 blood	 of	 patients	 with	 glucocorticoid	 resistance	 [174].	
Samples	were	immediately	plated	in	6-well	culture	plates	and	stimulated	with	10	ng	LPS	(E.	coli,	0127:B8,	
Sigma-Aldrich,	St.	Louis,	MO)	or	sterile	PBS.	Cell	supernatant	was	collected	4	h	later	for	cytokine	analysis	
and	cells	were	placed	directly	 into	1	mL	TRIzol®	Reagent	 (ThermoFisher	Scientific,	Grand	 Island,	NY)	to	
collect	total	RNA.		
3.3.6	Flow	Cytometry	
Hypothalamic	CD11b+	cells	were	 resuspended	 in	 flow	buffer	 [PBS	with	1%	BSA	 (ThermoFisher	
Scientific),	0.1%	sodium	azide	(Sigma-Aldrich),	and	20	mM	glucose	(Sigma-Aldrich)].	Competitive	binding	
of	the	Fc	receptor	was	blocked	with	purified	CD16/CD32	antibodies	(eBioscience,	San	Diego,	CA).		Cells	



























responses	 to	maternal	 infection	 within	 a	 litter	 [175].	 All	 data	 were	 subjected	 to	 analysis	 of	 variance	
(ANOVA)	 to	 reveal	 main	 effects	 and	 interactions,	 except	 the	 flow	 cytometry	 data	 and	 the	 litter	
characteristics	data	(Supplemental	Table	S3.3),	which	were	analyzed	using	a	Student’s	t	test	(two-tailed).	
Where	significant	main	effects	or	interactions	were	found,	Tukey	or	Bonferroni	post-hoc	test	results	are	












protein	data	 from	primary	hippocampal	CD11b+	cell	 cultures,	whereas	2-way	 (prenatal	 treatment	x	 in	
vitro	treatment)	ANOVAs	were	used	to	analyze	primary	hypothalamic	CD11b+	cell	culture	data.	The	spatial	
T-maze	task	data	were	analyzed	using	a	2-way	ANOVA	(prenatal	treatment	x	time).	Within-group	1-way	
ANOVAs	with	 Bonferroni	 post-hoc	 tests	 were	 used	 to	 determine	 chamber	 preferences	 in	 both	 social	
behavior	tests,	whereas	time	spent	actively	investigating	was	analyzed	using	2-way	(prenatal	treatment	x	
chamber)	ANOVAs.	 Two-way	ANOVAs	 (prenatal	 treatment	 x	 chamber)	with	 a	 Tukey	 post-hoc	 analysis	
were	also	used,	to	determine	chamber	preference	differences	between	treatment	groups	in	both	social	








Fig.	 3.2A).	 Plasma	 IL-6	 was	 below	 detectable	 levels	 for	 most	 samples,	 thus	 these	 data	 could	 not	 be	
analyzed	or	presented.	 To	avoid	 restraint	 stress	 in	 the	 current	 study,	weekly	blood	 samples	were	not	
collected.	Nonetheless,	pregnant	gilts	had	increased	core	body	temperature	from	GD	82-84	(6-8	d	post-
inoculation;	treatment	x	time,	p	<	0.01;	Fig.	3.2B),	and	decreased	food	intake	from	GD	83-87	(7-11	d	post-




















Microglia	 isolated	 from	 the	 hypothalamus	 of	 PD	 28	 (±	 1	 d)	 piglets	were	 stained	 for	 CD45,	 to	
differentiate	microglial	cells	from	infiltrating	monocytes,	and	MHC	II,	to	 indicate	phagocytic	activation.	









was	 associated	 with	 glucocorticoid	 resistance,	 microglia	 were	 isolated	 from	 the	 hippocampus	 and	
hypothalamus	of	PD	28	(±	1	d)	piglets	and	stimulated	with	LPS	(10	ng/mL)	±	DEX	(3.18	µM).	Expectedly,	








or	 hypothalamic	microglia.	 The	 same	 LPS	 x	 DEX	 interaction	 (p	 <	 0.001)	 was	 evident	 in	 TNFα	 protein	
concentrations	measured	in	cell	culture	media	from	hippocampal	microglia,	such	that	the	increase	in	TNFα	





concentrations	 in	 media	 from	 hypothalamic	 microglia	 (p	 <	 0.001,	 Fig.	 3.6B).	 DEX	 was	 not	 used	 as	 a	
treatment	for	hypothalamic	microglia	because	GR	regulation	in	the	pig	hippocampus	has	been	proven	to	













paradigm	 on	 PD	 27	 (±	 1	 d).	 Total	 time	 spent	 in	 each	 compartment	 throughout	 the	 10	 min	 test	 is	



































inflammatory	 response	 in	 gilts	 during	 a	 critical	window	of	 fetal	 neurodevelopment,	 piglets	 born	 from	
PRRSV-infected	gilts	did	not	display	a	pro-inflammatory	phenotype	at	PD	14	or	PD	28.	Our	results	are	in	
agreement	with	recent	data	from	a	rodent	model	of	MIA	[121,	122].	However,	this	does	not	exclude	the	








stressor	 that	 altered	 AMPH	 response	 in	 adulthood	 [179].	 Recent	 clinical	 data	 on	 patients	 with	
neuropsychiatric	disorders	support	the	absence	of	heightened	inflammatory	markers	at	birth	or	in	early	








adulthood	 [186].	 However,	 we	 were	 unable	 to	 detect	 an	 exaggerated	 immune	 or	 GC	 response	 to	 a	




immune	 phenotype	 of	 prenatally	 challenged	 offspring	 to	 a	 primed	 state	 [187-190].	 Indeed,	mounting	




(for	 review,	 see	 [191]).	 A	 recent	 investigation	 of	 the	 synaptic	 proteome	 of	 adolescent	 prenatally	
challenged	rats	 revealed	more	 than	100	significantly	altered	pre-	and	post-synaptic	proteins,	of	which	
more	than	50%	correlated	with	known	alterations	 in	schizophrenia,	a	disorder	where	symptoms	often	
emerge	 in	 adolescence	 [91].	 Giovanoli	 et	 al.	 (2016)	 also	 report	 emergence	 of	 postsynaptic	 deficits	 in	
pubescence,	while	presynaptic	deficits	emerged	in	adulthood	in	prenatally	challenged	mice	[122].	Using	
a	 single	 injection	 of	 LPS	 in	 dams	 at	 E16,	 Straley	 et	 al.	 demonstrated	 impaired	motor	 performance	 in	
offspring	tested	during	juvenile	and	adult	stages	but	not	during	adolescence	[179].	This	is	consistent	with	
multiple	poly	I:C	MIA	models,	which	do	not	induce	noticeable	behavioral,	cognitive,	or	pharmacological	
abnormalities	 in	 offspring	 until	 adulthood,	 perhaps	 due	 to	 post-pubertal	 maturational	 processes	
necessary	 for	 the	development	of	behavioral	abnormalities	[192].	Thus	evidence	of	aberrant	microglia	














models	 [123].	Ratnayake	et	al.	 (2012)	compared	 Iba1	staining	 in	PD	1	and	PD	100	mice	born	 to	dams	
exposed	 to	 poly	 I:C	 to	 show	 that	 the	 number	 of	microglial	 cells	 in	 the	 hippocampus	was	 significantly	
increased	at	PD	1,	and	 that	 these	microglia	demonstrated	a	more	amoeboid	phenotype,	compared	 to	
controls;	 these	differences	were	no	 longer	 apparent	 at	 PD	100	 [125].	 It	 is	 possible	 that	 an	undefined	
microglia	phenotype	exists	due	to	prenatal	challenge	but	this	was	not	detectable	in	our	model	due	to	the	
classical	 phenotypic	 markers	 used.	 Microglia	 serve	 widely	 varying	 functions	 that	 differ	 based	 on	
neurodevelopmental	 stage	 and	pathological	 states	 [63],	 and	 could	 fall	 anywhere	 along	 a	 spectrum	of	
activation	states,	some	of	which	may	not	be	classically	defined	[72].		
The	 most	 robust	 effect	 of	 maternal	 PRRSV	 infection	 was	 clear	 abnormalities	 in	 piglet	 social	
behaviors.	 Aberrant	 social	 behaviors	 are	 also	 observed	 in	 both	 rodent	 and	 non-human	 primate	MIA	
models	 [31,	 32,	 193-195].	 A	 deficit	 in	 social	 communication	 and	 interactions	 is	 one	 of	 the	 two	major	
criteria	for	diagnosis	of	Autism	Spectrum	Disorder	(DSM-IV).	Social	deficits	are	also	indicative	of	negative	
symptoms	of	schizophrenia,	namely	social	withdrawal	and	 impairments	 in	social	 functioning	 (DSM-IV).	
Pigs	are	a	social	species	[196,	197]	and	display	a	preference	for	novelty	exploration	[198],	thus	our	tests	
of	sociability	and	preference	for	social	novelty	are	ideal	for	this	species.	Oro-nasal	fixation	is	well	defined	
in	 swine	 [199,	 200]	 and	 serves	many	 purposes,	 including	 social	 recognition	 and	 affiliation	 [201].	 Pig-
directed	nosing	behavior	in	swine	has	been	shown	to	indicate	social	behavior	[201].	Here,	as	the	dog	crate	
allowed	for	limited	tactile	communication,	nose-to-crate	contact	was	used	to	define	social	behavior;	this	
also	allowed	 for	direct	 comparison	with	 the	empty	 crate.	 Though	differences	 in	nose-to-crate	 contact	










(scaffold	 proteins	 involved	 in	 the	 Wnt	 signaling	 pathway)	 reveals	 transient	 fetal	 brain	 growth	
abnormalities	linked	to	neuronal	progenitor	cell	proliferation	and	differentiation,	resulting	in	abnormal	





extensively	 expressed	 by	 microglia)	 indicates	 that	 microglia	 are	 integral	 in	 establishing	 functional	





IL-6-to-IL-17a	maternal	 pathway,	 such	 that	maternal	 IL-6	 augments	 TH17	 cell	 differentiation,	 inducing	
heightened	levels	of	maternal	IL-17a,	which	is	sufficient	to	produce	social	deficits	(along	with	several	other	
ASD-like	behaviors)	in	offspring.	Pre-treating	pregnant	dams	with	IL-17a-blocking	antibody	fully	rescued	
these	phenotypes	 [25].	 Evidence	 from	 studies	 investigating	 the	 interaction	of	maternal	 infection	with	
offspring	 epigenetics	 (reviewed	 in	 [204])	 suggests	 that	 there	 is	 likely	 also	 involvement	 of	 epigenetic	
regulation	(potentially	 through	maternal	 IL-6	and	 IL-17a	pathways)	 in	MIA-induced	ASD-like	behaviors.	
Though	the	exact	mechanism	has	yet	to	be	identified,	mounting	evidence	indicates	that	MIA	significantly	
alters	social	behaviors	in	offspring	[25,	31,	52,	205,	206].	
Glia	 other	 than	microglia	may	 also	 be	 involved	 in	 shaping	 the	 response	 of	 the	 fetal	 brain	 to	
maternal	 insult.	Recently,	astrocytes	have	been	 implicated	 in	MIA	models	utilizing	poly	 I:C	 [207,	208].	
Astrocytes,	 originally	 thought	 of	 as	 non-neuronal	 supportive	 cells,	 play	 a	 key	 role	 in	 normal	 brain	
development	and	in	mediating	synapse	activity;	they	also	express	many	of	the	same	pattern	recognition	
receptors	 found	 on	microglia	 and	 are	 able	 to	 secrete	many	 of	 the	 same	 anti-	 and	 pro-inflammatory	
cytokines	when	stimulated	by	classic	TLR	ligands	or	by	maternal	cytokines	[208].	Though	astrocytes	may	
have	a	critical	role	in	mediating	neurodevelopment	during	prenatal	infection,	there	is	still	ample	work	to	







































































































































































































































































































































































































	 Control	1	 Control	2	 Control	3	 PRRSV	1	 PRRSV	2	 PRRSV	3	 PRRSV	4	 PRRSV	5	
Group	1	 4	 6	 0	 9	 5	 0	 5	 0	
Female	 3	 5	 -	 5	 2	 -	 4	 -	
Male	 1	 1	 -	 4	 3	 -	 1	 -	
Group	2	 6	 5	 6	 3	 3	 1	 3	 7	
Female	 4	 5	 3	 2	 1	 -	 1	 2	






Gene	 Classification	 Accession	numbera	 Assay	identificationb	
GAPDH	 Reference	 NM_001206359	 Ss0337854_g1	
TNFα	 Pro-inflammatory	 NM_214022	 Ss03391318_g1	
IL-6	 Pro-inflammatory	 NM_214399	 Ss03384604_u1	
IL-10	 Anti-inflammatory	 NM_214041	 Ss03382372_u1	








Treatment	 Litter	Size	 Stillborn	 Live	Born	 Piglet	Birth	Wt.	(kg)	
Piglet	
Mortality	
Control	(n	=	3)	 14.7	±	2.6	 4.3	±	2.6	 10.3	±	2.6	 1.7	±	0.2	 0.14	





















brain	development,	particularly	 in	 the	hippocampus.	However,	 information	on	 the	effects	of	maternal	
viral	infection	on	fetal	brain	development	in	gyrencephalic	species	is	limited.	Thus,	the	objective	of	this	
study	 was	 to	 assess	 several	 effects	 of	 maternal	 viral	 infection	 in	 the	 last	 one-third	 of	 gestation	 on	
hippocampal	 gene	 expression	 and	 development	 in	 fetal	 piglets.	 Pregnant	 gilts	 were	 inoculated	 with	
porcine	reproductive	and	respiratory	syndrome	virus	(PRRSV)	at	gestational	day	(GD)	76	and	fetuses	were	
removed	by	cesarean	section	at	GD	111	(3	d	before	anticipated	parturition).	Gilts	infected	with	PRRSV	had	




gyrus	and	 subiculum.	The	number	of	proliferative	Ki-67+	cells	was	not	altered,	but	 relative	 integrated	
density	of	GFAP+	staining	was	increased,	in	addition	to	an	increase	in	GFAP	gene	expression,	indicating	
astrocyte-specific	gliosis.	Maternal	viral	infection	caused	an	increase	in	fetal	hippocampal	gene	expression	


























212].	 Indeed,	 animal	models	 of	maternal	 immune	 activation	 (MIA)	 have	 demonstrated	 that	 offspring	




recombinant	 IL-6	 to	 pregnant	 dams,	 the	 critical	 involvement	 of	 this	 particular	 cytokine	 in	 mediating	
offspring	 behavioral	 abnormalities	 [26].	 A	 potential	mechanism	 through	which	 IL-6	 accesses	 the	 fetal	
compartment	was	revealed	by	Wu	et	al.	(2016),	who	performed	a	restricted	deletion	of	the	IL-6	receptor	
on	placental	 trophoblasts	 to	prevent	 the	neurodevelopmental	pathologies	 caused	by	MIA	 [27].	 In	 the	
brain	 of	 fetuses	 exposed	 to	 maternal	 lipopolysaccharide	 (LPS)	 treatment,	 intracellular	 IL-6	 signaling,	
through	signal	transducer	and	activator	of	transcription	(STAT3),	is	increased	and	can	be	blunted	by	IL-6	
blocking	 antibody	 [27,	 28].	 A	 series	 of	 elegant	 studies	 performed	 in	 a	 rodent	 maternal	




















studies	 indicate	 that	 microglial	 cell	 activation	 in	 MIA	 is	 dependent	 on	 the	 timing	 and	 nature	 of	 the	
maternal	insult,	and	that	the	answer	to	whether	fetal	microglia	are	involved	in	MIA	etiology	is	still	not	
clear.	
Evidence	 does	 suggest,	 however,	 that	 the	 hippocampus,	 a	 region	 of	 the	 brain	 important	 for	
learning	and	memory,	may	be	particularly	vulnerable	 to	maternal	 insults.	Zhang	and	van	Praag	 (2015)	
have	demonstrated	that	maternal	treatment	with	poly	I:C	results	in	reduced	dentate	gyrus	volume	and	








We	 sought	 to	determine	 the	 impact	 of	maternal	 viral	 infection	on	 the	neonatal	 hippocampus	
using	a	pig	MIA	model.	The	domestic	piglet	serves	as	an	excellent	model	of	early	brain	development	due	




Here,	we	 inoculated	 pregnant	 gilts	with	 porcine	 reproductive	 and	 respiratory	 syndrome	 virus	
(PRRSV)	at	gestational	day	(GD)	76	and	fetuses	were	removed	by	cesarean	section	at	GD	111	(3	d	before	
parturition).	 PRRSV	 infects	 swine	 alveolar	 macrophages,	 leading	 to	 interstitial	 pneumonia	 [160];	
symptoms	include	anorexia,	fever	and	sometimes	cyanosis	[219],	similar	to	what	is	observed	with	human	
influenza	 infection	 [220].	Previous	 studies	 in	our	 lab	have	 shown	 that	early	postnatal	PRRSV	 infection	
results	in	reduced	neurogenesis	and	enhanced	microglia	activity	in	the	neonatal	hippocampus	[21,	163],	






prenatal	 exposure	 to	 maternal	 PRRSV	 infection	 causes	 altered	 social	 behaviors	 postnatally,	 while	
prolonged	 microglia	 activation	 is	 not	 evident	 [221].	 Thus,	 we	 aimed	 to	 characterize	 the	 impacts	 of	
maternal	 immune	 activation	 on	 hippocampal	 neurodevelopment	 and	 glial	 reactivity	 prenatally.	 We	
hypothesized	 that	 maternal	 PRRSV	 would	 alter	 fetal	 hippocampal	 development	 (decreasing	 neuron	






Eight	 pregnant	 crossbred	 (Large	 White/Landrace)	 gilts,	 PRRSV-free	 and	 not	 vaccinated,	 were	
brought	from	the	University	of	Illinois	swine	herd	into	the	biomedical	animal	facility	at	GD	69.	Gilts	were	








macrophages	 [160],	 and	 results	 in	 increased	 secretion	 of	 IL-1β,	 IL-6,	 and	 TNFα	 [161,	 162].	 	 Rectal	
temperature	and	feed	intake	were	monitored	daily.	Blood	was	collected	from	the	marginal	ear	vein	once	
weekly,	on	GD	76	(immediately	before	PRRSV	inoculation),	GD	83,	GD	90,	GD	97,	and	GD	104	(0,	7,	14,	21,	
and	 28	 days	 post	 infection	 [dpi],	 respectively).	 On	 GD	 111	 (35	 dpi),	 gilts	 were	 anesthetized	 using	 a	
telazol:ketamine:xylazine	drug	cocktail	(50	mg	of	tiletamine	plus	50	mg	of	zolazepam	reconstituted	with	



















All	 animal	 care	 and	 experimental	 procedures	were	 in	 accordance	with	 the	 National	 Research	
Council	Guide	 for	 the	 Care	 and	 Use	 of	 Laboratory	 Animals	 and	 approved	 by	 the	 University	 of	 Illinois	
Institutional	Animal	Care	and	Use	Committee.	
4.3.2	Microglia	cell	isolation	and	flow	cytometry	
Microglia	 cells	were	 isolated	 from	hippocampal	 tissue	 based	 on	 positive	 expression	 of	 CD11b	
using	 the	 Miltenyi	 Biotec	 neural	 cell	 isolation	 procedure,	 as	 described	 previously	 [221].	 Briefly,	 cell	











a	marker	of	phagocytic	 cell	 activation.	Cells	were	 flowed	 through	 the	FACS	Aria	 II	 flow	cytometer	 (BD	
Biosciences,	 San	 Jose,	 CA)	 and	 gated	 based	 on	 the	 forward-	 and	 side-scatter	 and	 autofluorescence	
properties	 of	 a	massed	 unstained	 control	 sample.	 Cells	were	 confirmed	 as	 CD11b+	microglia	 cells	 by	













Total	 RNA	was	 extracted	 from	 the	 hippocampus	 of	 each	 fetus	 using	 E.Z.N.A	 Total	 RNA	 kit	 11	
(Omega,	 Norcross,	 GA,	 USA)	 and	 cDNA	was	 synthesized	 using	 a	 QuantiTect	 Reverse	 Transcription	 Kit	
(Qiagen,	Valencia,	CA).	Quantitative	real-time	PCR	was	performed	using	the	Applied	Biosystems	TaqMan	
Gene	Expression	Assay	protocol.	The	custom	TaqMan	Low	Density	Array	card	consisted	of	384	wells	and	






























The	 cresyl	 violet	 stained	 sections	 were	 scanned	 on	 a	 Nanozoomer	 (Hamamatsu	 Photonics,	
Hamamatsu,	Japan)	slide	scanner	at	40X	magnification.	The	images	were	exported	to	20X,	and	the	CA1,	
CA3,	and	subiculum	regions	were	manually	traced	using	the	free	hand	tool	in	Image	J,	then	the	number	

































and	 incubated	 in	 biotinylated	 secondary	 antibody	 (1:200,	 goat	 anti-mouse	 antibody,	 Jackson	





GFAP	 and	 Ki-67	 stained	 sections	 were	 scanned	 using	 a	 nanozoomer	 (Hamamatsu	 Photonics,	



















removed	 from	 those	 models.	 Outliers	 were	 identified	 using	 SAS	 code	 “proc	 boxplot,	





analysis	 of	 piglet	 brain	 weight,	 body	 weight,	 gene	 expression,	 hippocampal	 estimated	 neuronal	 cell	
counts,	and	flow	cytometry	data.	A	student’s	t-test	was	used	to	analyze	IL-6	concentration	in	gilts.	In	the	
current	study,	each	piglet	was	considered	an	experimental	unit	as	pigs	are	multiparous	species,	where	



























(p	 <	 0.0001)	 on	 fetal	 body	weight.	 Fetuses	 from	 PRRSV-inoculated	 gilts	 had	 decreased	 brain	weights	









0.06%;	MIA:	0.36	±	0.08%).	There	was	a	decrease	 in	 the	percent	of	microglia	expressing	MHCII	 in	 the	
prenatal	infection	group	(p	<	0.001),	though	it	is	uncertain	whether	this	is	physiologically	relevant.		
4.4.5	Fetuses	from	PRRSV-infected	gilts	displayed	altered	hippocampal	gene	expression				




































In	 the	 present	 study,	 we	 demonstrate	 that	 late-gestation	maternal	 PRRSV	 infection	 causes	 a	
reduction	 in	 fetal	 viability	 and	brain	weight,	which	 is	 accompanied	by	decreases	 in	 relative	density	of	
neurons,	 upregulation	 of	 GFAP-specific	 gliosis,	 and	 altered	 gene	 expression	 in	 the	 hippocampus.	
Hippocampal	microglia	did	not	appear	to	be	activated	and	there	were	no	differences	in	cell	proliferation	
at	GD	111,	which	leads	us	to	suspect	that	fetal	microglia	are	instead	acutely	activated	by	maternal	viral	
infection,	 causing	 the	 observed	 alterations	 in	 hippocampal	 development,	 and	 that	 this	 activation	 is	
resolved	by	parturition.	It	is	important	to	note	that	most	of	the	existing	literature	on	MIA	is	from	rodents,	
which	 differ	 from	 both	 pigs	 and	 humans	 in	 their	 anatomy	 and	 physiology	 and	 their	 innate	 immune	
responses	[17,	18,	229].	It	should	be	acknowledged	that	rodents	are	not	always	the	ideal	animal	model	







Maternal	 PRRSV	 infection	 resulted	 in	 febrile,	 anorectic,	 and	 inflammatory	 cytokine	 (IL-6)	
responses	 in	 pregnant	 gilts	 post-inoculation,	 and	 the	 presence	 of	 the	 virus	 in	 maternal	 serum	 was	
confirmed	 through	 rtPCR.	 We	 have	 previously	 shown	 that	 plasma	 TNFα	 is	 also	 elevated	 in	 PRRSV-
inoculated	gilts	on	GD	83,	90,	and	97	(7,	14,	and	21	dpi,	respectively;	treatment	x	time,	p	<	0.0001)	[221].	
PRRSV	 infection	 during	 gestation	 results	 in	 increased	 incidences	 of	 abortion,	 premature	 delivery,	 and	
increased	 neonate	 mortality	 [219].	 Here,	 maternal	 PRRSV	 infection	 increased	 piglet	 mortality,	 in	
agreement	with	reports	of	reproductive	failure	due	to	 late-gestation	PRRSV	 infection	[231-233].	While	
transplacental	fetal	infection	does	occur,	there	was	no	significant	effect	of	positive	viral	infection	on	any	
analyses	 in	 our	 model.	 Epidemiological	 studies	 assessing	 the	 risks	 of	 maternal	 infection	 on	 offspring	
psychiatric	 disorders	 indicate	 that	 both	 pathogens	 that	 are	 transmissible	 to	 the	 fetus	 (rubella	 virus,	
cytomegalovirus,	herpes	simplex	virus,	toxoplasma	gondii)	and	those	that	are	non-transmissible	(influenza	
virus)	confer	 risk	 [1,	2];	animal	models	 strongly	suggest	 that	 the	maternal	 inflammatory	 response	 (i.e.	
cytokines	such	as	IL-6	and	IL-17a),	and	not	the	pathogen,	drive	the	detrimental	effects	of	MIA	on	offspring	
neurodevelopment	 and	 behavior	 [25-27].	 Thus,	 in	 our	 model,	 PRRSV	 infection	 serves	 to	 activate	 a	




development.	 It	 is	 important	 to	 note	 that	 piglets	 obtained	 from	 infected	 gilts	 had	 comparable	 body	
weights	to	those	obtained	from	control	gilts,	indicating	that	maternal	infection	did	not	cause	intrauterine	
growth	restriction	(IUGR)	or	low	birth	weight	(LBW)	fetuses.	In	most	cases	of	IUGR,	fetuses	undergo	an	
adaptive	brain-sparing	 response	 that	 results	 in	asymmetrical	 growth,	wherein	only	body	 size,	 and	not	
brain	size,	is	reduced	[234].	In	our	MIA	model,	there	is	no	increase	in	the	incidences	of	IUGR	or	LBW	piglets	
[seen	 here	 and	 previously	 [221]];	 to	 the	 contrary,	 it	 appears	 that	 MIA	 fetuses	 undergo	 inverse	
asymmetrical	growth,	wherein	body	weight	is	spared	but	brain	weight	is	reduced.				
Estimated	neuronal	cell	density	in	the	dentate	gyrus	and	neuronal	cell	counts	in	the	subiculum	
were	 significantly	 decreased	 in	 GD111	 fetal	 brains	 exposed	 to	maternal	 infection,	which	 could	 partly	
explain	 the	 reduction	 in	brain	weight.	One	possibility	 that	could	account	 for	 this	decrease	would	be	a	
reduction	in	neurotrophic	factors.	Yet,	NGF,	BDNF,	NTRK3,	and	NTF3	gene	expression	was	unaltered	by	
maternal	 infection	 at	 GD111.	 Expression	 of	markers	 involved	 in	 synaptic	 activity	 (synaptophysin)	 and	
pruning	[TGF-β	and	CX3CL1;	[82,	83]]	were	also	unchanged.	Interestingly,	NGF	expression	was	reduced	in	














point,	pre-	or	postnatally	 [47].	Poly	 I:C	 is	a	viral	mimetic	 immunogen	that	binds	TLR3,	so	the	maternal	
inflammatory	 mechanisms	 initiated	 during	 poly	 I:C	 challenge	 mimic	 what	 is	 seen	 during	 active	 viral	
infection,	like	PRRSV.	This	could	explain	why	no	differences	were	observed	here	in	the	expression	of	either	
gene.	As	both	NGF	and	BDNF	are	 important	 regulators	of	neuronal	survival	and	differentiation,	 future	
research	designed	 to	map	 the	 response	of	 these	markers	 over	 time,	 and	 across	 sex,	 to	different	MIA	
challenges,	is	needed.		
A	two-fold	increase	in	expression	of	MBP	was	also	observed	in	the	fetal	hippocampus	at	GD	111.	
This	 is	 in	contrast	with	 the	current	 literature	demonstrating	 impaired	myelination	 in	prenatal	 immune	
activation	models,	 including	 studies	 focused	 on	 the	 hippocampus	 [91,	 236,	 237];	 and	 summarized	 in	
[238]).	However,	as	MBP	mRNA	was	only	examined	at	one	time	point	in	the	current	study,	we	surmise	
that	MBP	gene	expression	may	 follow	 the	 same	pattern	as	previous	 studies	 if	 examined	during	acute	
maternal	 infection,	and	that	the	 increase	 in	expression	observed	three	weeks	post-inoculation	may	be	
indicative	of	a	compensatory	mechanism,	though	further	studies	will	need	to	be	conducted	to	verify	this	
hypothesis.		




as	 microglia	 and	 produce	 the	 same	 cytokines,	 to	 respond	 to	 MIA	 insults	 and	 participate	 in	
neurodevelopmental	alterations.	MIA	models	utilizing	poly	I:C	are	arguably	the	most	similar	to	the	live	
viral	 infection	 used	 here,	 and	 it	 is	 plausible	 that	 virally-mediated	 maternal	 infections	 follow	 similar	






As	established	by	Cunningham	et	 al.	 (2013),	 activation	of	microglial	 cells	 by	MIA	 can	 result	 in	
excessive	 phagocytosis	 of	 neural	 precursor	 cells,	 which	 causes	 a	 decrease	 in	 neuronal	 numbers	 that	
endures	postnatally	[60].	In	our	model,	an	indication	of	excessive	neural	progenitor	cell	phagocytosis	was	






survey	 their	 environment	 and	 can	 engulf	 and	 clear	 parenchymal	 debris	 [74].	 In	 agreement	 with	 the	




behaviors	 postnatally	 [221].	 Gene	 expression	 of	 CD200	 (the	 CD200R	 ligand	 expressed	 by	 neurons,	
astrocytes	 or	 oligodendrocytes	 to	 signal	 microglia	 inhibition)	 tended	 to	 be	 upregulated,	 indicating	 a	
potential	attenuation	of	microglial	activation	[240];	expression	of	CD200R	was	unchanged.	
Differences	 in	 hippocampal	 inflammatory	 gene	 expression	 indicated	 enduring	 impacts	 of	
maternal	viral	infection	on	the	innate	immune	responses	of	the	fetal	CNS.	In	agreement	with	the	altered	
fetal	 brain	 cytokine	 balance	 hypothesis	 [30],	 gene	 expression	 of	 TNFα	 and	 IFNγ	 were	 significantly	





preferentially	 derived	 from	 glia	 during	 neuroinflammatory	 states,	 is	 a	 powerful	 inhibitor	 of	 neurite	
outgrowth	 and	branching	 [242].	 Further	 in	 vitro	work	 suggests	 that	 TNFα,	 IL-1β,	 and	 IL-6	 can	directly	
impact	 neuron	 dendrite	 development	 such	 that	 the	 overall	 complexity	 of	 developing	 neurons	 is	
significantly	 reduced,	 similar	 to	what	 is	 seen	 in	disorders	 like	schizophrenia	 [37].	Expression	of	STAT3,	
activated	by	 IL-6	signaling,	tended	to	be	 increased.	 IL-6	signaling	has	been	shown	to	be	necessary	and	

















but	was	not	 impacted	by	maternal	 infection.	HSP70,	which	has	been	 linked	 to	 the	pathophysiology	of	
schizophrenia	[244],	is	involved	in	protein	folding	and	protects	against	both	thermal	and	oxidative	cellular	
stress.	A	reduction	in	HSP70	in	the	brains	of	schizophrenics	appears	to	contribute	to	reduced	cognitive	
function	 [245],	 and	 the	 sexual	 dimorphism	 observed	 in	 the	 incidence	 of	 psychiatric	 disorders	 like	
schizophrenia	and	autism	in	human	populations	[higher	in	males	[5,	246]]	indicates	that	male	piglets	may	
be	more	 at	 risk	 of	 developing	behavioral	 abnormalities	 in	 our	model.	 Chemokine	 (C-C	motif)	 ligand	2	
(CCL2),	also	known	as	monocyte	chemoattractant	protein	1	(MCP-1),	recruits	monocytes	and	microglia	





[64].	 Thus,	 further	 investigation	 into	 the	 potential	 impacts	 of	 sexual	 dimorphism	 in	 CCL2	 expression,	
specifically	within	the	context	of	MIA,	is	needed.				
In	 conclusion,	we	demonstrate	 that	maternal	 viral	 infection	 in	 swine	 increases	 fetal	mortality,	
decreases	fetal	brain	weight,	and	alters	hippocampal	development	by	decreasing	estimated	neuronal	cell	
density	and	increasing	GFAP	expression	immediately	prior	to	parturition.	Hippocampal	gene	expression	
revealed	 significant	 increases	 in	 TNFα	 and	 IFNγ,	 and	 a	 trending	 increase	 in	 IL-1β	 and	 STAT3,	 while	







MHCII	 expression	 by	 microglia	 revealed	 a	 decrease	 in	 both	 protein	 and	 gene	 expression	 at	 GD	 111,	
indicating	that	classical	microglia	activation,	if	present,	may	be	resolved	by	this	time.	Future	studies	will	



































































































































Fig.	4.5.	Maternal	viral	 infection	resulted	 in	an	 increased	relative	 integrated	density	of	GFAP	staining	 in	the	hilar	
region	of	the	hippocampus.	(A)	Representative	image	of	GFAP	stained	cells	in	the	hilus	of	fetuses	born	to	control	
and	PRRSV-inoculated	gilts	at	5X	and	10X	magnifications.	Arrows	identify	representative	positively-stained	cells	in	
















































Treatment	Group	 Litter	Size	 Viable	Piglets	 Non-viable	Piglets	
Control	(n	=	4)	 12.8	±	1.5	 12.5	±	1.3	 0.3	±	0.3	
PRRSV	(n	=	4)	 11.3	±	1.3	 8.3	±	0.5*	 3.0	±	1.6*	
p-value	 ns	 p	=	0.023	 p	=	0.048	
Data	are	means	±	SEM.	The	authors	would	like	to	note	that	the	current	study	was	not	designed	to	detect	significant	
















risk	 of	 psychiatric	 disorders	 like	 Autism	 Spectrum	 Disorder,	 though	 the	 mechanisms	 remain	 to	 be	
elucidated.	We	 have	 previously	 established	 a	maternal	 immune	 activation	 (MIA)	 swine	model,	 which	
results	 in	 altered	 piglet	 social	 behaviors	 postnatally,	 in	 the	 absence	 of	microglia	 activation.	 Thus,	 we	
sought	 to	 identify	 microglia	 activity	 prenatally,	 immediately	 following	 maternal	 infection,	 and	
hypothesized	that	MIA	would	elicit	transient	fetal	microglia	activation	concomitant	to	maternal	symptoms	






classical	 activation	 marker	 MHCII	 and	 displayed	 reduced	 chemotactic	 activity	 compared	 to	 controls.	
Phagocytosis	was	also	reduced	in	MIA	microglia	at	7	dpi,	but	not	21	dpi.	High-throughput	gene	expression	























connections	 [90].	 Altered	 microglial	 activity	 during	 development,	 therefore,	 can	 have	 long-lasting	
injurious	consequences.	Specifically,	altered	microglial	activity	has	been	linked	to	pathological	forebrain	
wiring	 and	 disrupted	 functional	 connectivity	 across	 limbic	 and	 cortical	 neural	 networks,	 as	well	 as	 to	
behavioral	deficits,	all	characteristic	of	neuropsychiatric	illnesses	like	Autism	Spectrum	Disorder	(ASD)	[79,	
89,	90].	Maternal	infections	during	pregnancy	have	specifically	been	linked	to	an	augmented	risk	of	ASD	









the	 impacts	of	maternal	 infection	on	microglial	activation	during	 the	prenatal	period.	Stimulating	MIA	
with	viral	mimetic	polyinosinic:polycytidylic	acid	(poly	I:C)	at	embryonic	day	(E)	12.5	or	E14.5	has	been	
shown	 to	 shift	 gene	 expression	 profiles	 of	 newborn	 mouse	 microglia	 towards	 a	 more	 advanced	





Bacterial	mimetic	 lipopolysaccharide	(LPS)	 is	also	widely	used	to	 induce	MIA	 in	rodents;	 it	was	
recently	demonstrated	that	three	consecutive	maternal	LPS	injections	on	E15,	16,	and	17	in	mice	increases	













during	 late	 gestation.	 Previous	 data	 from	 our	 lab	 confirms	 the	 manifestation	 of	 altered	 behaviors	
indicative	 of	 neurodevelopmental	 dysregulation	 in	 neonatal	 piglets,	 namely	 reduced	 sociability	 and	
preference	for	social	novelty	[221].	We	have	also	shown	that	fetal	piglets	exposed	to	MIA	have	reduced	
neuronal	density	in	the	hippocampus	and	evidence	of	astrogliosis	before	birth	[249].	Using	this	model,	we	
sought	 to	characterize	 the	 function	and	phenotypes	of	 fetal	microglia	both	during	peak	maternal	viral	
infection	and	after	maternal	symptoms	had	resolved.		
We	 found	 that	 fetal	 porcine	microglia	 increase	 the	 expression	 of	 classical	 antigen	 presenting	
marker	 MHCII	 in	 response	 to	 MIA,	 but	 not	 surface	 glycoprotein	 CD68.	 Unexpectedly,	 we	 show	 that	




increased	 microglial	 density	 only	 in	 the	 fetal	 amygdala,	 while	 microglia	 morphology	 was	 relatively	




are	 transiently	 but	 significantly	 altered	 by	 MIA,	 providing	 a	 possible	 mechanism	 for	 the	 disrupted	
neurodevelopment	and	social	behavior	previously	observed	in	our	model.	More	broadly,	our	data	suggest	























0.04	 mL/kg	 body	 weight	 telazol:ketamine:xylazine	 (TKX)	 drug	 cocktail	 (50	 mg	 tiletamine	 plus	 50	 mg	






Upon	 confirmation	 of	 euthanasia,	 cesarean	 sections	 were	 performed	 as	 previously	 described	
[249].	 In	 brief,	 the	 uterus	 and	 both	 ovaries	 were	 removed	 and	 litter	 size	 was	 determined	 by	 gently	
palpating	the	uterus.	Fetuses	were	given	unique	IDs,	beginning	closest	to	the	ovary,	for	each	left	and	right	















formalin	 and	 preserved	 for	 immunohistochemistry.	 Specific	 regions	 of	 interest	 (including	 the	















































system	 (101-8;	 Neuro	 Probe,	 Inc.,	 Gaithersburg,	MD).	 Samples	 were	 plated	 in	 replicates	 of	 4	 for	 the	
phagocytosis	assay,	and	replicates	of	5	for	the	chemotaxis	assay.	
5.3.7	RNA	extraction,	cDNA	synthesis,	and	quantitative	real-time-PCR	
Total	 RNA	 from	 gilt	 and	 fetal	 tissues	 was	 extracted	 using	 the	 TRI	 Reagent®	 protocol	 (Sigma-
Aldrich,	St.	Louis,	MO).	One-to-four	µg	of	RNA	was	used	to	synthesize	cDNA	using	a	High	Capacity	cDNA	
Reverse	 Transcription	 Kit	 (Applied	 Biosystems,	 Grand	 Island,	 NY).	 Quantitative	 real-time	 PCR	 was	
















cDNA	 from	 fetal	 microglia	 and	 amygdala	 tissue	 was	 submitted	 to	 the	W.M.	 Keck	 Center	 for	
Comparative	 and	 Functional	 Genomics	 (University	 of	 Illinois,	 Urbana,	 IL)	 for	 quantitative	 PCR	 analysis	
using	 the	 Biomark	 HD	 Fluidigm®	 high-throughput	 amplification	 system.	 Forty-eight	 genes	 of	 interest	
(selected	from	[78];	TaqMan	assays;	Supplemental	Table	S5.2)	were	assessed	on	the	96	x	96	platform,	
and	all	samples	were	run	in	duplicate.	Data	were	analyzed	using	the	Biomark	&	EP1	Real-Time	PCR	Analysis	




















Digital	 images	of	 Iba1-stained	 slides	were	obtained	at	 40X	magnification	using	a	NanoZoomer	
(Hamamatsu	 Photonics,	 Hamamatsu,	 Japan).	 Images	 were	 analyzed	 using	 the	 NDP.view2	 software	



















0.10.	 ‘Proc	mixed’	or	 ‘proc	glm’	procedures	were	used	 in	SAS	9.4	 for	almost	all	 analyses;	a	 ‘repeated’	




weight	 and	 left	 and	 right	 uterine	 horn	 placement.	 Though	 most	 analyses	 were	 underpowered	 for	
comparisons	across	sex,	sex	was	included	in	most	models	and	main	effects	of	sex	or	MIA*sex	interactions	
are	reported	throughout;	all	fetal	groups	were	balanced	for	sex	when	possible.	The	authors	would	like	to	



























































interaction	 p	 =	 0.10;	 Table	 5.3)	 at	 21	 dpi,	 with	 female	 MIA	 fetuses	 expressing	 more	 Cx3cl1	 mRNA	
compared	to	MIA	males,	though	expression	did	not	differ	between	control	males	and	females.		
In	the	fetal	hypothalamus,	MIA	caused	a	reduction	in	both	Il-6	and	IL-1	receptor	antagonist	(Il-





Primary	microglia	 (CD11b+	CD45low)	 isolated	 from	 fetuses	at	both	7	and	21	dpi	were	assessed	



















females,	 regardless	of	maternal	 treatment	 (control	 female:	1.7	±	 0.3%,	 control	male:	2.0	±	 0.3%;	MIA	
female:	1.6	±	0.2%,	MIA	male:	2.2	±	0.3%).	Interestingly,	the	percent	of	CD11b+	CD45low	cells	expressing	
CD68	significantly	decreased	from	7	to	21	dpi	(p	<	0.0001;	7	dpi:	28.5	±	0.6%,	n	=	79;	21	dpi:	11.9	±	0.8%,	







post-stimulation.	 Interestingly,	MIA	did	not	 impact	production	and	release	of	TNFα	by	 these	cells,	but	
gestational	timing	did,	such	that	microglia	isolated	at	GD	83	and	treated	with	saline	or	LPS	produced	more	
TNFα	 at	 baseline	 and	 post-LPS	 stimulation	 compared	 to	 microglia	 isolated	 at	 GD	 97	 (in	 vitro	
treatment*gestational	day	interaction,	p	<	0.0001;	Fig.	5).	However,	no	such	effect	was	observed	in	cells	








Using	 high-throughput	 qPCR,	 47	 target	 genes	 (listed	 in	 Supplemental	 Table	 S5.2)	 involved	 in	
















males	 in	 all	 affected	 genes	 (marked	 with	 yellow	 asterisks;	 Fig.	 5.6A;	 means	 separations	 listed	 in	
Supplemental	Table	S5.4).	The	most	striking	example	of	this	effect	can	be	seen	in	the	expression	of	type	
II	 interferon	 Ifng,	where	MIA	caused	an	upregulation	 in	male	 fetuses,	but	a	downregulation	 in	 female	
fetuses	(Table	S5.4).		
At	21	dpi,	only	3	genes	were	impacted	by	the	interaction	between	MIA	and	sex,	while	13	genes	











































decreased	 in	MIA	offspring	compared	 to	controls	 [221].	We	hypothesized	 that	 this	gene	set	would	be	











S5.5).	 Interestingly,	 gene	 expression	 of	 the	 cell	 surface	marker	Cd4	 (typically	 expressed	 by	 peripheral	
immune	 cells	 like	 T	 helper	 cells,	 monocytes/macrophages,	 and	 dendritic	 cells,	 but	 also	 induced	 in	
microglia	in	some	pathological	conditions	[252])	tended	to	be	downregulated	in	males	(p	=	0.08;	Fig.	5.7A),	
in	contrast	to	all	other	genes	impacted	by	sex	or	the	interaction	between	MIA	and	sex.	Only	3	genes	were	
impacted	 by	 sex	 alone	 at	 7	 dpi	 (purinergic	 receptor	 P2ry12,	 cell-adhesion	molecule	 selectin	 P	 ligand	


























did	 not	 significantly	 impact	 microglia	 number,	 a	 skewing	 of	 microglia	 towards	 a	 more	 phagocytic	
































brain	 development	 emerging	 within	 3	 weeks	 post-inoculation.	 Inflammation	 at	 the	 maternal-fetal	
interface,	a	 likely	pathway	through	which	maternal	cytokines	signal	to	the	fetal	brain	[27,	36,	43],	was	
present	even	after	maternal	symptoms	resolved.	Global	changes	in	fetal	microglia	were	evidenced	first	by	
increased	 expression	of	MHCII	 and	 changes	 in	 phagocytic	 and	 chemotactic	 capacity,	with	 evidence	of	




microglial	 characteristics,	 such	 as	 production	 of	 TNFα	 and	 cell	 morphology	 and	 density	 in	 the	
hippocampus	and	amygdala	are	specifically	impacted	by	gestational	timing,	coinciding	with	maturation	




the	 chief	 mediators	 of	 altered	 neurodevelopment	 and	 behavior	 in	MIA	models.	 Here,	 we	 show	 that	
pregnant	gilts	infected	with	PRRSV	have	increased	levels	of	IL-6	as	well	as	TNFα	in	circulation,	and	that	
these	elevated	levels	persist	even	after	sickness	symptoms	have	resolved.	Although	swine	do	have	TH17	
























not	 upregulated	 in	 the	 porcine	 placenta	 at	 either	 time	 point;	 however,	 it	 is	 important	 to	 note	 that	
placentas	 from	 rodent	 studies	 were	 assessed	 within	 hours	 of	 MIA	 induction,	 which	 likely	 does	 not	
physiologically	align	with	the	7	and	21	dpi	time	points	presented	here.	Thus,	signaling	of	IL-6	through	the	





and	 is	used	as	an	 indicator	of	active	phagocytosis	 [260];	 though	both	MHCII	and	CD68	can	be	used	as	
markers	for	microglia,	expression	patterns	fluctuate	with	changes	in	cell	morphology	and	activation	status	
[259,	261],	and	CD68	in	particular	can	be	expressed	by	both	‘alternatively’	or	‘classically’	activated	cells.	
Both	 CD68	 and	 MHCII	 are	 expressed	 by	 microglia	 in	 the	 developing	 brain	 [60,	 253],	 and	 are	 often	
upregulated	during	development	to	enhance	phagocytic	capacity.	Here	we	show	that	even	though	MHCII	
was	 expressed	 at	 low	 levels	 within	 both	 treatment	 groups,	 microglia	 from	 MIA	 fetuses	 displayed	 a	
significant	2-3%	increase	in	this	antigen	presenting	molecule	at	both	time	points,	indicating	a	slight	shift	




aligns	with	 the	phenotypes	of	 embryonic	 rodent	 and	non-human	primate	microglia	 that	 are	primarily	
amoeboid	and	phagocytic	during	development	[60],	but	shift	to	a	more	ramified	state	as	they	mature.	Our	
data	indicate	that	microglial	CD68	expression	may	therefore	be	a	good	marker	for	cell	maturation	during	






















to	 suggest	 that	 perturbing	microglia	 during	 neurodevelopment	 has	 significant	 effects	 on	 neuron	 and	
oligodendrocyte	survival,	but	whether	this	can	be	attributed	solely	to	(1)	an	increase	in	phagocytosis	of	
otherwise	healthy	neuroprogenitors	or	 to	 (2)	 a	 removal	of	 trophic	 support,	 is	unknown.	Thus,	 further	






capacity)	 compared	 to	neonatal	porcine	microglia,	 though	 further	 studies	 are	needed	 to	 confirm	 this.	
Intriguingly,	production	of	 inflammatory	cytokine	TNFα	by	fetal	microglia	 in	vitro	did	not	appear	to	be	
impaired,	as	TNFα	protein	in	cell	culture	media	was	increased	by	both	poly	I:C	and	LPS,	mirroring	previous	
results	 [163].	 Thus,	 basic	 inflammatory	 responses	 appear	 to	 be	 intact	 in	 porcine	 fetal	 microglia,	 and	
though	production	of	TNFα	is	not	affected	by	MIA,	gestational	timing	reduced	the	total	protein	that	was	









downregulated.	These	 included	developmental	and	sensome	genes,	 like	 trophic	 factors	and	purinergic	
receptors.	Neurotrophin	BDNF,	which	is	produced	by	microglia	to	promote	new	synapse	formation	[263],	





microglia	 development	 [264]	 and	 for	 resolution	 of	 neuroinflammation	 [265].	 During	 embryonic	
development,	TGF-β	signaling	is	vital	for	microglial	cell	survival	[264]	and	helps	maintain	a	more	quiescent	





compared	to	control	 females.	Decreased	expression	 in	males	was	still	apparent	at	21	dpi,	 though	MIA	







cells).	 ATP	 can	 act	 at	 synapses	 or	 surround	 injured	 or	 apoptotic	 cells	 and	 typically	 causes	 responding	
microglia	 to	 become	 hyper-ramified	 [269].	 At	 the	 synapse,	 P2RY12	 activation	 aids	 in	 the	 eventual	
phagocytosis	 of	 inactive	 synapses	 during	 pruning	 [270].	 During	 experimentally-induced	 neuronal	
hyperactivity,	P2RY12	 is	 required	 for	extension	of	 ramified	microglial	processes	around	swollen	axons,	
initiating	neuroprotective	membrane	repolarization	and	phagocytic	clearance	of	debris	[76].	Thus,	P2RY12	
can	also	be	used	as	a	marker	for	assessing	cell	activation	as	it	is	highly	expressed	during	resting/surveying	
states,	 but	 considerably	 reduced	during	 classical	 amoeboid	 activation	 [261,	 269].	Here,	we	 show	 that	
P2ry12	mRNA	is	reduced	in	MIA	microglia	at	7	dpi,	and	that	in	control	conditions,	male	microglia	have	





























Altered	 expression	 of	 other	 developmental	 and	 sensome	 genes,	 like	 macrophage	 colony	
stimulating	 factor	Csf1,	cell-cycle	genes	Cdk1	and	Egr1,	and	Tyrobp	 (which	encodes	DAP12),	were	also	
evident.	 CSF-1	 receptor	 (CSF-1R),	 expressed	 constitutively	 on	 microglia,	 is	 essential	 for	 microglial	
colonization	 and	 proliferation	 during	 development	 and	 for	 proliferation	 and	 survival	 throughout	 the	
lifespan	 [128,	 253].	 Although	 CSF-1R	was	 not	measured	 here,	Csf1	 is	 especially	 enriched	 in	microglia	
during	neurodevelopment	[67].	Csf1	tended	to	be	decreased	in	female	microglia	at	7	dpi,	and	was	robustly	
reduced	 at	 21	 dpi	 in	MIA	microglia,	 suggesting	 a	 decline	 in	 autocrine	 signaling	 and	 potentially	 in	 cell	


















Remarkably,	 MIA	 in	 mice	 was	 sufficient	 to	 cause	 increased	 microglial	 density	 and	 a	 more	 activated	
microglial	phenotype,	resulting	in	impaired	signaling	at	synapses	similar	to	what	is	seen	in	DAP12	mutant	
mice	 [117].	Our	data	 suggest	 that	a	 comparable	phenotype	may	be	 induced	by	MIA	 in	 swine.	Pattern	





using	an	MIA	mouse	model,	 though	adult	 and	not	embryonic	microglia	were	assessed	 [124].	Notably,	
Mattei	et	al.	(2017)	found	that	genes	involved	in	microglial	phagocytosis	were	disrupted	in	their	model,	
including	those	that	complexed	with	and	were	involved	in	signaling	of	Tyrobp	[124].	Similar	genes	were	
differentially	 regulated	 in	 porcine	 fetal	 microglia	 in	 the	 present	 study,	 indicating	 that	 alterations	 to	
microglial	phagocytosis	may	be	a	primary	route	by	which	MIA	impacts	both	fetal	and	adult	brain	function.	
Though	 expression	 of	 pro-inflammatory	 cytokines	 (such	 as	 IFNγ,	 IL-1β,	 IL-6,	 and	 TNFα)	 by	

















7	dpi.	Expression	of	 interferon-induced	 Ifit3	was	also	downregulated	by	MIA	 in	microglia	at	7	dpi,	and	
tended	to	have	differential	regulation	at	21	dpi	due	to	MIA	and	sex.	Amplification	of	Ifng	was	inconsistent	
across	amygdala	tissue,	and	was	thus	excluded	from	analyses,	while	expression	of	Ifit3	was	impacted	by	
the	 interaction	of	MIA	and	 sex	at	7	dpi,	 though	 this	normalized	by	21	dpi.	Aside	 from	a	 tendency	 for	
differential	expression	due	to	the	interaction	between	MIA	and	sex	at	7	dpi	 in	microglia,	expression	of	





























































the	 fetal	 amygdala	 may	 regulate	 social	 behavior	 deficits	 in	 later	 life.	 Physiological	 gene	 expression	
patterns	in	fetal	porcine	microglial	cells	were	similar	to	that	of	rodents	[67,	78],	and	preliminary	data	on	
the	 effects	 of	 sex	 indicate	 that	 sexual	 dimorphisms	 during	 neurodevelopment	 are	 a	 species-wide	


























































Fig.	 5.4.	Percentage	of	 primary	 fetal	microglia	 (CD11b+	 CD45low)	 from	 litters	 of	 PRRSV-infected	 gilts	 had	 greater	
expression	of	MHCII,	 but	not	CD68,	 compared	 to	 litters	of	 control	 gilts	 at	21	dpi	 (±	1	d).	 Percentage	of	primary	
microglia	expressing	(A)	MHCII	(**	=	main	effect	MIA,	p	<	0.01),	(B)	CD68,	or	(C)	both	MHCII	and	CD68.	N	=	5	litters	
per	group;	n	=	47-50	fetuses	per	group.	Primary	fetal	microglia	from	litters	of	PRRSV-infected	gilts	had	phagocytic	











Fig.	 5.5.	Maternal	 infection	 did	 not	 impact	 production	 of	 pro-inflammatory	 cytokine	 TNFα	by	 primary	microglia	
stimulated	with	saline,	poly	 I:C	 (1	μg/mL),	or	LPS	 (1	ng/mL).	However,	TNFα	protein	concentration	 in	media	was	
reduced	in	cells	isolated	at	GD	97	(21	dpi)	compared	to	GD	83	(7	dpi;	in	vitro	treatment	x	gestational	day,	p	<	0.0001).	
Four	million	primary	cells	per	piglet,	per	treatment;	n	=	7-16	fetuses	per	group.	***	=	individual	ANOVA	for	each	in	






























































Body	Wt.	(g) Brain	Wt.	(g) N Body	Wt.	(g) Brain	Wt.	(g) N 
Control 530.9	±	13.9 14.9	±	0.2 45 854.7	±	18.9 25.2	±	0.3 50 






































































Gene	 Accession	Number	 Category	 Assay	IDa	
Ccl2	 NM_214214	 Immune	 Ss03394377_m1		
Cd200rb	 custom	 Immune	 custom	
Cx3cl1	 DQ991100	 Immune	 Ss03377157_u1		
Cxcr3	 AJ851240	 Immune	 Ss03375858_u1	
Ifng	 NM_213948	 Immune	 Ss03391054_m1	
Il-10	 NM_214041	 Immune	 Ss03382372_u1	
Il-1b	 NM_214055	 Immune	 Ss03393804_m1	
Il-1ra	 NM_214262	 Immune	 Ss03383715_u1		
Il-6	 NM_214399	 Immune	 Ss03384604_u1	
Il-6r	 NM_214403	 Immune	 Ss03394904_g1	
SLA-DRA	(MHCII)	 NM_001113706	 Immune	 ss03389942_m1	
Nf-kb	 NM_001048232	 Immune	 Ss03388575_m1		
Rpl19	 AF435591	 Housekeeping	 ss03375624_g1	
Stat3	 NM_001044580	 Immune	 Ss03388426_m1		










Gene	 Accession	Number	 KEGG	Ortholog		 Category	 Applied	Biosystems	Assay	IDa	
Bdnf	 NM_214259	 K04355	 Development	 Ss03822335_s1	
C1qa	 NM_001003924	 K03986	 Development	 Ss03378489_u1	
C5	 NM_001001646	 K03994	 Development	 Ss03391586_m1	
Ccr5	 NM_001001618	 K04180	 Sensome	 Ss03378121_u1	
Ccrl2	 NM_001001617	 K08373	 Sensome	 Ss03378109_u1	
Cd14	 NM_001097445	 K04391	 Sensome	 Ss03818718_s1	
Cd180	 NM_214357	 K06555	 Sensome	 Ss03384320_s1	
Cd4	 NM_001001908	 K06454	 Sensome	 Ss03391676_m1	
Cd40	 NM_214194	 K03160	 Sensome	 Ss03394337_m1	
Cd74	 NM_213774	 K06505	 Sensome	 Ss03381367_u1	
Cd86	 NM_214222	 K05413	 Sensome	 Ss03394401_m1	
Cdk1	 NM_001159304	 K02087	 Development	 Ss03372912_g1	
Crybb1	 NM_001078681	 No	KO	assigned	 Development	 Ss03388726_m1	
Csf1	 AJ583705	 K05453	 Development/Sensome	 Ss03373560_g1	
Cxcl16	 NM_213811	 K10035	 Sensome	 Ss03381587_u1	
Cxcr2	 AK230995	 K05050	 Development	 Ss03375929_g1	
Dnmt1	 NM_001032355	 K00558	 Development	 Ss03392016_m1	
Dnmt3a	 NM_001097437	 K17398	 Development	 Ss03385484_u1	
Egr1	 AJ238156	 K09203	 Development	 Ss03373483_s1	
Fcer1g	 NM_001001265	 K07983	 Sensome	 Ss03391475_m1	
Fcgr2b		 NM_001033013	 K12560	 Sensome	 Ss03392060_m1	
Fcgr3		 NM_214391	 K06463	 Sensome	 Ss03384597_u1	
Ifit3	 NM_001204395	 No	KO	assigned	 Development	 Ss04248506_s1	
Ifng	 NM_213948	 K04687	 Immune	 Ss03391054_m1	
Ifngr1	 NM_001177907	 K05132	 Sensome	 Ss04246620_m1	
Il-10	 NM_214041	 K05443	 Immune	 Ss03382372_u1	
Il-1b	 NM_214055	 K04519	 Immune	 Ss03393804_m1	
Il-17a	 NM_001005729	 K05489	 Immune	 Ss03391803_m1	
Il-6	 NM_214399	 K05405	 Immune	 Ss03384604_u1	
Il-8	 NM_213867	 K10030	 Immune	 Ss03392437_m1	
Itgam	 JF709973	 K06461	 Immune/Sensome	 Ss03374588_m1	
Itgb5	 NM_001246669	 K06588	 Sensome	 Ss04322936_m1	
Ly86	 NM_001097415	 No	KO	assigned	 Sensome	 Ss03388794_m1	
Cxcl2		 NM_001001861	 K05505	 Immune	 Ss03378360_u1	
Nos2	 NM_001143690	 K13241	 Immune	 Ss03374608_u1	
P2ry12	 NM_001173518	 K04298	 Sensome	 Ss03373817_s1	
P2ry6	 NM_001244296	 K04272	 Sensome	 Ss03376684_u1	
RelA	 NM_001114281	 K00951	 Immune	 Ss03253758_m1	
Rpl19	 AF435591	 N/A	 Housekeeping	 ss03375624_g1	
Selplg		 NM_001105307	 K06544	 Sensome	 Ss04328834_s1	
Slc2a5	 EU012359	 K08143	 Sensome	 Ss03377332_u1	
Tgfb1	 NM_214015	 K13375	 Development	 Ss03382325_u1	
Tgfbr1	 NM_001038639	 K04674	 Sensome/Development	 Ss03392139_m1	
Tlr2	 NM_213761	 K10159	 Sensome	 Ss03381278_u1	
Tnfa	 NM_214022	 K03156	 Immune	 Ss03391318_g1	
Tnfrsf1b	 NM_001097441	 K05141	 Sensome	 Ss03385518_u1	
Tpi1	 NM_001037151	 K01803	 Development	 Ss03379689_u1	






Treatment	Group	 Litter	Size	 Viable	Piglets	 Non-viable	Piglets	
Control	(n	=	10)	 11.1	±	1.1	 9.5	±	1.3	 1.6	±	0.6	





































































prenatally.	 This	built	 the	 foundation	 for	our	 follow-up	experiments.	Additional	 characterization	of	 the	
prenatal	piglet	hippocampus	showed	reduced	neuron	density	as	well	as	astrogliosis	several	days	before	







Data	 from	 these	 final	 experiments	 demonstrated	 that	 indeed	 fetal	 microglia	 undergo	 global	
changes	 in	 pro-inflammatory	 MHCII	 expression,	 gene	 expression,	 phagocytosis	 and	 chemotaxis,	 and	
overall	cell	density	in	specific	brain	regions	at	the	peak	of	maternal	infection.	These	responses	tended	to	
return	to	baseline,	as	predicted,	following	the	resolution	of	outward	maternal	symptoms,	which	aligns	












neurodevelopmental	 processes	 and	 brain	 growth.	 An	 overall	 reduction	 in	 microglial	 chemotaxis,	





density),	 including	 failure	of	proper	synaptic	connections,	 that	persists	even	after	microglial	 responses	
have	returned	to	baseline.	Following	parturition,	the	detrimental	impacts	of	microglial	malfunction	are	
evident	in	the	emergence	of	altered	social	behaviors	in	neonatal	piglets.		
However,	 there	are	conceptual	 leaps	 in	this	proposed	mechanism	that	should	be	addressed	 in	
future	investigations.	First,	extensive	research	has	recently	been	undertaken	to	eloquently	demonstrate	
the	contribution	of	pro-inflammatory	cytokine	IL-17a	in	a	mouse	model	of	MIA	[25,	38,	39,	210].	Though	
we	were	 able	 to	measure	 circulating	 plasma	 IL-17a	 in	 pregnant	 gilts,	maternal	 viral	 infection	 did	 not	
appear	 to	 impact	 these	 concentrations,	 at	 least	 not	 at	 7	 or	 21	 dpi.	 Additionally,	 we	 were	 unable	 to	
measure	 IL-17a	 or	 IL-17Ra	 mRNA	 in	 either	 maternal	 or	 fetal	 tissues,	 leaving	 this	 particular	 pathway	
relatively	unexplored.	Given	the	compelling	evidence	suggesting	that	IL-17a	is	necessary	and	sufficient	to	
induce	offspring	abnormalities	in	a	mouse	model,	the	contributions	of	IL-17a	in	our	particular	swine	model	





















the	 field	 as	 well	 as	 in	 our	 particular	 swine	 model.	 As	 has	 been	 demonstrated	 with	 rodents,	 specific	




concentration	of	 pro-inflammatory	 cytokines	 in	 fetal	 circulation	 that	were	 acquired	 through	maternal	
blood,	if	any,	as	well	as	to	delineate	the	contribution	of	signaling	across	the	placenta.		
Finally,	 potential	 routes	 to	 ameliorate	 microglial	 dysfunction	 need	 to	 be	 explored.	 Previous	
studies	have	shown	beneficial	outcomes	with	the	use	of	antibiotic	tetracycline	(minocycline	[124,	282]),	





gut	 microbiome	 and	 innate	 immune	 responses,	 both	 peripheral	 [283]	 and	 central	 [111,	 112])	 when	
considering	translatability	to	humans.	The	importance	of	the	maternal	microbiome	composition	during	
MIA	has	recently	been	demonstrated,	and	is	vital	for	inducing	IL-17a	during	the	response	to	poly	I:C	insult	
in	 dams	 [39].	 Undoubtedly,	maternal	 antibiotic	 administration	would	 play	 a	 substantial	 role	 in	 these	
mechanisms,	and	careful	dissection	of	the	microbial	changes	in	dams	and	in	offspring	should	be	performed	
if	tetracycline	treatments	are	to	be	considered	viable	therapeutic	options.		
Collectively,	 our	 results	 indicate	 that	 acute	 disruptions	 in	 fetal	microglial	 activity	 immediately	
following	 maternal	 inflammation	 have	 prolonged	 impacts	 on	 neurodevelopmental	 and	 inflammatory	







































from	 Chapter	 5	 indicate	 that	 there	 are	 7	 fetal	 microglial	 actions	 that	 are	 altered:	 (1)	 shift	 from	 a	
homeostatic	phenotype;	(2)	decreased	phagocytosis;	(3)	decreased	chemotaxis;	differential	expression	of	
genes	involved	in	(4)	synaptic	pruning	and	(5)	synaptogenesis;	differential	expression	of	genes	involved	in	
(6)	 trophic	 support	 and	 (7)	 cell	 proliferation.	 Ultimately,	 there	 is	 increased	 microglial	 density	 in	 the	
amygdala	at	7	dpi,	and	reduced	neuron	density	in	the	hippocampus	at	35	dpi.	Overall,	these	changes	result	
in	altered	social	behaviors	postnatally.	 	
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